We have identified a number of immuno-inflammatory conditions where there are currently no FDA-approved treatments. Our research is laser focused on addressing these unmet needs using our mechanism-driven next-generation therapeutics and improving the quality of life of patients suffering from these debilitating conditions.

Copyright © 2024 Vyome Therapeutics, Inc. All rights reserved.
Developed by Kenovate Solutions

Targeting immuno-inflamation and rare diseases